Cardiff Oncology, Inc. (CRDF) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Cardiff Oncology, Inc. (CRDF) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $115.5M, listed on NASDAQ, employing roughly 32 people, carrying a beta of 1.36 to the broader market. Cardiff Oncology, Inc. Led by Mani Mohindru, public since 2004-07-27.
Snapshot as of May 15, 2026.
- Spot Price
- $1.67
- Total OI
- 33.1K